Guardian Pharmacy Services, Inc. reported significant financial growth in its latest quarterly results, with revenues reaching $329.3 million for the three months ended March 31, 2025, marking a 19.6% increase from $275.4 million in the same period of the previous year. The company's gross profit also rose to $64.3 million, up from $55.1 million, while net income increased to $9.3 million compared to $7.1 million in the prior year. This growth was attributed to both organic expansion and acquisitions, with the latter contributing approximately $21.1 million to the revenue increase.
The company experienced notable operational changes, including an increase in the number of residents served, which grew from 164,000 to 189,000, and an increase in prescriptions dispensed from 5.8 million to 6.7 million. Additionally, Guardian Pharmacy expanded its footprint, serving approximately 7,000 long-term care facilities across 38 states. The company’s employee headcount also increased, contributing to a rise in selling, general, and administrative expenses, which totaled $51.3 million, up from $47.2 million in the previous year.
Strategically, Guardian Pharmacy completed several acquisitions in 2024, with total consideration amounting to $17.4 million, including cash and contingent earnout payments. These acquisitions are expected to enhance the company’s market position in the long-term care pharmacy sector. The company also underwent a corporate reorganization prior to its initial public offering (IPO) in September 2024, which has positioned it for future growth as a publicly traded entity.
The financial outlook for Guardian Pharmacy remains positive, with management expressing confidence in the company’s ability to continue expanding its market share in the long-term care pharmacy industry. The company anticipates that its strategic focus on both organic growth and acquisitions will sustain its upward trajectory. As of March 31, 2025, Guardian Pharmacy held $14.0 million in cash and cash equivalents, which, along with expected cash flows from operations, is projected to support its working capital and capital expenditure needs for the foreseeable future.
About Guardian Pharmacy Services, Inc.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.